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DETECTION METHOD FOR LIQUIDS USING 
NEAR INFRARED SPECTRA 
This Application is a continuation-in-part of US Ser. 
No. 07/414,799 ?led Sept. 29, 1989, now abandoned. 
BACKGROUND OF THE INVENTION 
Biotechnology has created a number of new and 
potentially life-saving products Many of these products 
cannot withstand exposure to the digestive tract as an 
oral formulation and must instead be formulated as 
injectables. Furthermore, these molecules may not sur 
vive terminal sterilization by autoclaving. In these 
cases, an aseptic-?lling process is required although it is 
a less reliable sterilization method, making detection of 
unsterile products a necessary task. Conventional mi 
crobiological methods and turbidimetry are currently 
employed as inspection techniques to assess sterility. 
However, these procedures are typically very time 
consuming, invasive, and may not detect low levels of 
contamination. 
In more detail, many drugs must be formulated as 
parenteral products (injectables), and delivered in a 
solution contained in a sterile vial or intravenous (IV) 
bag. Maintaining the stability of the drug (preventing 
decomposition) and insuring the sterility of the drug 
(absence of microbial growth) can be a problem. 
Preservative systems and sterilization procedures for 
parenteral products must be well monitored (see Henry 
L. Avallone, J. Parenter. Sci. T echnoI. 1985, 39(2), 
75-79) and tested by validated microbiological methods 
(see “Validation of Steam Sterilization Cycles”, Techni 
cal Monograph No. l, and “Validation of Aseptic Fill 
ing For Solution Drug Products”, Technical Mono 
graph No. 2, Parenteral Drug Association, Inc., 1980). 
The typical method of assuring the sterility of vials and 
IV bags is to ?ll them with the desired product and 
sterilize the ?nal ?lled product by autoclaving (see John 
Y. Lee, Pharmaceutical Technology 1989, 13(2), 66-72). 
Unfortunately, the autoclaving process can also stress 
fragile molecules and denature proteins. In such cases, 
the IV bag or vials are filled aseptically (under condi 
tions that are as sterile as possible) and sterilized by 
?ltration with a 0.2 pm ?lter. The product can then be 
used. 
Unfortunately, sterility by aseptic ?lling is not as 
certain as with terminal sterilization (autoclaving). It 
has been estimated that terminal sterilization by auto 
claving results in a sterility assurance level of 10"6 or 
better (probability of an unsterile unit), while aseptic 
?lling generally achieves an assurance level of only 
10"3 or one contaminated unit per thousand (see Qual 
ity Control Reports: The Gold Sheet, in F-D-C Reports, 
Bill Paulson, Ed., 1988, 22(3), 1-6 and Henry L. Aval 
lone, J. Parenter. Sci Technol. 1986, 40(2), 56-57). Be 
cause of this difference in sterility assurance levels FDA 
is requiring manufacturers who produce aseptically 
?lled products to submit methods and data justifying 
why terminal sterilization cannot be used. The manufac 
turer must also describe the microbiological monitoring 
and control procedures used to assure sterility (see 
FDA Guideline on Sterile Drug Products Produced by 
Aseptic Processing; Food and Drug Administration, 
Rockville, Md., July, 1987). 
The challenge to the analyst is to determine which 
product is contaminated and to prevent its use, assuring 
that the ?nal occurrence of defective units is very low. 
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Perhaps the simplest method of assuring product steril 
ity involves the incubation of an IV bag or vial until any 
microorganisms that might be present grow sufficiently 
numerous that turbidity develops. The turbidity is then 
detected by ordinary optical methods or by visual ex 
amination. Also, microscopic examination would reveal 
the identity of the contaminating microorganism(s). 
Unfortunately, it can take a signi?cant amount of time 
for turbidity to develop, and products contaminated 
with small amounts of microorganisms such as bacteria, 
molds, or yeast might not show visible turbidity. Fur 
thermore, some IV bags or vials are composed of mate 
rials that interfere with the visible detection of turbid 
ity. 
U.S. Pat. No. 4,367,041 to Webb teaches a liquid 
chromatography method where pure components of a 
mixture may be separated during chromatography by 
measurement of the ratio of absorbance at two wave 
lengths. 
A system for detecting the tampering of capsules 
using near-infrared (near-IR) light is described by Ro 
bert A. Lodder et al. in Anal. Chem. 1987, 59, 
1921-1930. Near-IR methods are commonly applied to 
the analysis of aqueous samples, see Robert A. Lodder 
et al., Appl. Spectrosc. 1988, 42, 518-519 and have been 
used in the detection of contaminated products, see 
Robert A. Lodder et al., Appl. Spectrosc. 1988, 42(8), 
1351-1357 and 1500-1512, and Appl. Spectrosc. 1988, 
42(4), 556-558. 
An analytical method that would enable the detection 
of low levels of microorganisms in parenteral products 
without the need for incubation for a long period of 
time would represent a signi?cant advance in the analy 
sis of parenteral products. Such a method would prefer 
ably be used to detect contamination by bacteria, yeast, 
or molds in drug vials and IV bags. 
SUMMARY OF THE INVENTION 
The present invention comprises an analytical 
method based on the near-IR light intensity change, 
e.g., light scattering or absorption, as a method for 
detecting small quantities of microorganisms in drug 
products e g., in sealed bags or vials. The method is 
noninvasive and nondestructive, preventing possible 
contamination of bag or vial units by the analytical 
method itself Ordinarily, sterility testing and microbial 
identi?cations are accomplished by looking at only a 
small number of units from the total lot of a product 
because these microbiological tests are, time consum 
in g, laborious, invasive, and in essence destroy the prod 
uct that is being examined. 
Near-IR light back-scattering is used as a method for 
determining low levels of contamination noninvasively 
and nondestructively. The method is used to detect 
contamination by yeast, mold, and/or bacteria with a 
detection limit potentially as low as three cfu of yeast 
per mL. Using the near-IR method of the invention, 
each container, e.g. IV bag or vial, can be evaluated 
intact with its sterility maintained, allowing the product 
to be used or evaluated by another method. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 depicts 11 traces of the near infrared spectra 
of a PVC IV bag containing 5% dextrose injection USP 
and 0.5 mg per mL of ranitidine as the hydrochloride. 
The “log l/R” indicates the logarithm of the reciprocal 
of the re?ectance intensity of the radiation. 
5,187,368 
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FIG. 2 is a depiction of 11 separate spectra as set forth 
in FIG. 1 with the exception that the IV bag of 5% 
dextrose solution USP and 0.5 mg per mL ranitidine has 
been contaminated with Pseudomonas aeruqinosa 
(ATCC No. 9027). 
FIG. 3 is the most common appearance of a QQ plot 
of the training set (the points on the left half of the plot) 
and the test set (the points on the right half of the plot). 
FIGS. 4, 5, and 6 depict the typical growth measured 
in cfu for a standard bacteria, yeast and mold, respec 
tively, in l50-mL PVC IV bags containing aqueous 5% 
dextrose and 0.5 mg/mL ranitidine as the hydrochlo 
ride. 
FIGS. 7 and 8 depict the spectra for PVC IV bags 
containing 5% aqueous dextrose without and with digi 
tal ?ltering,‘ respectively. 
FIG. 9 depicts near-IR spectra of IV bags containing 
5% dextrose and 0.5 mg/mL ranitidine after mathemati 
cal preprocessing as described herein with the upper 
trace being for a sterile bag and the bottom trace being 
for the bag contaminated with bacteria. 
FIG. 10 depicts 12 spectra from a bag contaminated 
with bacteria compared to 11 spectra acquired from an 
uncontaminated bag. 
FIG. 11 depicts the change in correlation of test bags 
as mold, yeast and bacteria grow in the bag compared to 
their respective values immediately after inoculation. 
DETAILED DESCRIPTION OF THE 
INVENTION 
As used in the present speci?cation, a near-IR spec 
trum is a spectrum of the scattering (or re?ectance) of 
light introduced into a liquid sample. This is a physical 
phenomenon and is, in effect, a de?ecting of the inci 
dent near-IR light. Such is not an absorbance or trans 
mittance spectrum as in the more typical IR spectra 
which are indicative of the individual chemical struc— 
tural features, of a chemical compound. Since the scat 
tering method of the invention depends on the amount 
of scattered (or re?ected) light, any absorbance in the 
liquid sample will decrease the quantity of light avail 
able for scattering. 
The present invention comprises a method for the 
detection of microorganisms in a liquid sample to be 
tested, which comprises the step of obtaining a near-IR 
spectrum of the liquid sample and then comparing the 
spectrum to a standard sample. In more detail, the de 
tection of microorganisms will often be for the purpose 
of determining sterility (or.the lack of sterility) in the 
liquid sample. Examples of microorganisms include any 
living cells which are individually not detected by vi 
sual inspection. Speci?c examples include yeast, bac 
teria or mold. The liquid sample to be tested is, in partic 
ular, water or an aqueous IV solution such as a solution 
of dextrose, typically 5% (w/v), or isotonic sodium 
chloride solution e.g., about 0.9% w/v. Other liquid 
samples that can be evaluated according to the method 
of the present invention include aqueous solutions used 
as growth media for fermentation stock or the growth 
of other cells. In this case, one would detect the pres 
ence and quantity of cells in order to determine whether 
or not there is sufficient population of the cells for the 
purpose intended. In contrast, if the method of the pres 
ent invention were used to determine sterility, the ob 
ject of the exercise would be to con?rm whether or not 
the liquid sample is sterile as seen by the absence of 
microorganisms. 
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Typical microorganisms to be detected according to 
the method of the present invention include yeast, bac 
teria and mold. Other cells include algae and other 
living cell lines such as cancer cell lines. 
The infrared spectrum to be taken according to the 
method of the present invention is a spectrum in 'the 
range of about 800-2500 nanometers (rim), more partic 
ularly 1100-1360 nm. The spectrum can be taken on any 
conventional near-IR spectrophotometer such as the 
InfraAlyzer 500 from Bran+ Luebbe of Elmsford, N.Y., 
the 6500 spectrophotometer from NIR Systems of Sil 
ver Springs, Md. and the Quantum 1200 spectropho 
tometer from LT Industries of Silver Springs, Md. In 
particular, the InfraAlyzer 500 can be used according to 
the method of the' present invention because it is a dou 
ble beam instrument and therefore need not be cor 
rected for variations such as ?uctuations in source in 
tensity. 
The near-IR spectrophotometer utilized is con?gured 
to detect scattering of the incident beam or changes in 
back-re?ected light intensities because of absorption 
processes. Detection of scattered or back-re?ected light 
from the incident beam can be accomplished by install 
ing equipment for light scattering as known in the art. 
For example, the EDAPT-l probe, available from 
Bran+Luebbe is suited for this purpose. Adaptation of 
commercially available near-infrared spectrophotome 
ters for the detection of scattered light is described by 
Robert A. Lodder et al. in Appl. Spectrosc. 1988, 42, 
518-519 and in Appl. Spectrosc. 1988, 42(4), 556-558. 
Other methods for detecting light scattering to be used 
in the method of the present invention are those de 
scribed in the chapter entitled “Molecular Scattering 
Methods” in Spectrochemical Analysis by James D. Ingle 
and Stanley R. Crouch, pp. 494-524, Prentice Hall_._ 
Englewood Cliffs, N.J., 1988. 
The liquid sample to be tested according to the inven 
tion is, in particular, held in a container which is at least 
partially transparent to at least one wavelength of near 
infrared light. As the spectrophotometer scans the near 
infrared sp ®ctrum at those wavelengths wherein both 
the liquid medium and the container holding the me 
dium are at least partially transparent, the spectropho 
tometer will then detect changes in the light that passes 
through the container and medium and is re?ected back 
or scattered due to the presence of the microorganisms 
to be detected. Examples of the container include bags, 
bottles, tubes, vials and ampules of glass (e.g., high 
grade borosilicate glass) or an organic polymer (e.g., 
PVC, polyethylene and CR3 polymer from Abbott 
Laboratories, Chicago, 111.). In particular, the method 
of the invention can be used to detect the sterility or loss 
of sterility, being more precise, of a liquid for parenteral 
administration to humans. Examples of parenteral ad 
ministration include IV and intramuscular injections or 
irrigation of a wound or other body cavity. The liquid 
medium may be composed of only a ?uid for adminis 
tration or it may contain a pharmaceutical formulation 
such as ranitidine hydrochloride injection. In addition 
to checking the sterility of an aseptically re?lled con 
tainer, wherein a concern is the growth of microorgan 
isms, the method of the present invention can also be 
used, conversely, to check the presence of such micro 
organisms that are bene?cial e.g., wherein one would 
want to check that the growth of bacteria in a fermenta 
tion broth had been proceeding satisfactorily. A partic 
ular application of the present invention is the determi 
5,187,368 
5 
nation of sterility in an aseptically-?lled container 
adapted for administration of its contents to a human. 
Once the spectra for the test sample and standard 
(“training”) samples are obtained, the spectra are com 
pared. Comparison may be by visual inspection of the 
spectra (e.g., in the range of 1100-1360 nm by measur 
ing the log of the reciprocal of re?ectance). In general, 
several e. g., 10 spectra ‘will be taken for each sample at 
various locations through the container. The trace of 
each of the spectra of the negative log of re?ectance (or 
the log of the reciprocal of re?ectance) are considered 
With a liquid sample having an absence of microorgan 
isms e.g., a sterile product, the various traces of the 
spectra taken at different portions of the container will, 
in general, have the same shape. In contrast, traces of a 
product with microorganisms present will show differ 
ent shapes for the spectra when taken through different 
portions of the container. In fact, the traces will often 
cross and such crossing is a good indicator of the pres 
ence of microbial contaminants 
An analysis of the distribution quantiles of near-IR 
spectral data (Robert A. Lodder et al. in Appl. Spectrosc. 
1988, 42(8), 1512-1520) provides a powerful means of 
interpreting light-scattering results. The principal ad 
vantage of the near-IR light-scattering method is that 
every single unit of the. product can be examined for 
sterility without invading and destroying the product. 
Furthermore, the method appears able to differentiate 
between different types of microorganisms in solution 
as well as to isolate the location of the organisms inside 
the container and determine the number of microorgan 
isms present. 
The determination of microorganisms according to 
the invention is based predominantly upon scattering of 
near-IR light by solid objects inside the container, e.g. 
sealed IV bag or vial. Monochromatic near-IR light is 
directed into the sample, and the solid material in the 
sample scatters light back into an integrating sphere for 
collection and detection. A ?ber-optic diffuse-re?ect 
ance probe is used to collect spectral data from a near 
IR beam with a wavelength range from 1100-1360 nm. 
Light is directed into the sample from a ?ber-optic 
bundle that is placed in the integrating sphere, e.g. a 
one-inch gold sphere directly opposite the sample win 
dow (or beam port). A reference ?ber-optic bundle is 
also present to direct near-IR light into the integrating 
sphere (refer ®nce beam). In particular, one may use 
such a pseudo-double-beam con?guration to compen 
sate for noise caused by bending of the ?ber and by 
source intensity variations. Signal values are recorded 
as a ratio of intensities between the sample and refer 
ence beams. The logarithm of the reciprocal of the 
re?ectance intensity recorded by this method is trans 
mitted to a computer such as a MicroVAX II for analy 
SIS. 
EXAMPLE 1 
Equipment. The spectrometer used to generate the 
near-IR light that was transmitter through the optical 
?bers was an InfraAlyzer 500 scanning spectrophotom 
eter (Bran+Luebbe, Inc., Elmsford, NY). The data 
were actually collected on an IBM PS/2 model 50 com~ 
puter (IBM Corp., Armonk, NY.) running IDAS soft 
ware (Bran+Luebbe). The collected re?ectance values 
were then transferred to a MicroVAX 11 computer 
system (Digital Equipment Corp., Maynard, Mass.) and 
an IBM 3090-300E vector supercomputer. Spectral data 
were processed in Speakeasy IV Epsilon (Speakeasy 
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Computing Corp., Chicago, IL) programs that were 
written speci?cally for this purpose. 
Materials. Thirty PVC IV bags containing 5% dex 
trose Injection USP (Via?ex ® 150-mL containers, 
Lot# C092445, Baxter Healthcare Corp., Deer?eld, 
111.) were injected with 3-mL of Zantac ® Injection 25 
mg/mL ranitidine as the hydrochloride, Glaxo Inc., 
Research Triangle Park, N.C.). Bags were injected 
through the additive port with a sterile disposable sy 
ringe and 21 GX 1.5 in. needle (Becton Dickinson, 
Rutherford, N.J.). The nominal ranitidine concentration 
in each bag was 0.5 mg/mL. 
The microorganisms injected into the bags included: 
Candida albicans (American Type Culture Collection 
number 10231), Aspergillus niger (ATCC'no. 16404), and 
Pseudomonas aeruginosa (ATCC no. 9027). These mi 
croorganisms were chosen to include a species of yeast, 
mold, and bacteria, respectively, which are typically 
tested to meet USP and FDA requirements. 
The inoculum was prepared by transferring the re 
spective microorganism from a lyophilized culture onto 
a solid agar medium and incubating at suitable tempera 
tures for suf?cient growth. For Pseudomonas aerugi 
nosa, Trypticase Soy Agar was used, and the incubation 
time was 18-24 hrs. Sabouraud Dextrose Agar was used 
for Candida albicans and Aspergillus niger with incuba 
tion times of 40-48 hrs and 7 days, respectively. These 
agars and incubation times are consistent with harvest 
ing procedures for pharmaceutical microbiological as 
says (see “Preparation of Inoculum", Section <5l>, 
USP XXII, United States Pharmacopeial Covention, 
1989). 
Cells were harvested into a sterile conical tube with 
5% Dextrose Injection USP instead of sterile saline TS 
to be consistent with the diluent used in the IV bags. 
Cell concentrations for each species were adjusted to a 
target range of 10-100 cfu‘ per 0.10 mL (100-1000 
cfu/mL) using 5% Dextrose Injection USP. This range 
was selected to give a starting target concentration of 
approximately 1 cfu/mL per bag, which represents a 
reasonable contaminant load for a sterility violation. 
The number of cfu per mL in the inoculum of each 
species was determined in quadruplicate by the spread 
plate method. The average inoculum concentrations 
from four plates were 1650 cfu/mL, 100 cfu/mL, and 
120 cfu/mL for Pseudomonas aeruginosa, Candida albi 
cans, and Aspergillus niger, respectively. 
The additive port of each of the 30 bags was injected 
with 0.10 mL of inoculum from one of the three micro 
organisms (10 bags of each type). The bags were in 
verted several times to distribute the cells throughout 
the bag. 
Data Analysis. A spectral training set was con 
structed for each group of 10 bags containing a single 
variety of microorganism. The spectral training set was 
collected immediately after injection of the microorgan 
isms. Spectra were also obtained from the bags before 
injection of the microorganisms. These spectra, how 
ever, were not used as the training set because the near 
IR method appeared to detect the injection of medium 
and microorganisms, which results in a large distur 
bance in the spectra. All ten bags containing the same 
organism were inoculated sequentially prior to the 
training-set scans. The time lag between the scanning of 
the first bag and tenth bag was approximately one hour. 
Furthermore, 12 scans over the wavelength range from 
1100-1360 nm were taken from each bag at different 
portions of the bag. Therefore, each training set con 
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sisted of 10 IV bags containing one of three microorgan 
isms in a 5% dextrose solution with drug. Twelve scans 
were taken from each bag so that each of the three 
training sets contained 120 spectral scans. During spec 
tral analysis, a spectrum recorded at 130 wavelengths in 
the 1100-1360 nm region was projected as a single point 
in a 260-dirnensional hyperspace. Thus, each training set 
was composed of a cluster of 120 points in a 260-dimen 
sional hyperspace. The analytical procedure located the 
center of the training set from the spectra recorded at 
time-zero in a 260-dimensional space and integrated 
outward steadily in all directions in space from the 
center of this training set to the “edges” of the training 
set cluster (the edges are de?ned typically as being three 
multidimensional standard deviations away from the 
center). This integral forms a function that is compared 
to a second integral, which is determined by i;-» egrating 
from the center of the combined training set and test set 
of spectra (where the test set is the spectra of the same 
group of IV bags as the training set although at a later 
time, such as 6, 12, 24 or 48 hrs after the injection of 
microorganisms). The 260-dimensional points from 
these test-set bags scanned at the later times are pro 
jected into the same space as the training-set spectra to 
form an augmented spectral cluster. Integrating from 
the center of the augmented set out in all directions at a 
constant rate produces a second integral. A plot of the 
?rst integral versus the second integral is used to form a 
QQ plot. 
Microorganism concentrations in bags 1 and 10 from 
each group were measured at O, 6, l2, l8, and 24 hrs by 
removing 0.40 mL of solution from each bag with a 0.5 
mL syringe. A 0.10-mL aliquot (or diluted aliquot at 
high microbiological concentrations) was transferred to 
each of four plates to determine the average cell con 
centration in cfu/mL. Trypticase Soy Agar was used as 
a growth medium for Pseudomonas aeruginosa aliquots, 
colonies were counted after 48 hrs at 30°-35° C. The 
results of the counts are shown in FIG. 4. Sabouraud 
Dextrose Agar was used as the growth medium for 
Candida albicans and Aspergillus niger aliquots, and 
colonies were counted after 72 hrs and 7 days, respec 
tively, at 20°—25° C. These data are presented in graphi 
cal form in FIGS. 5 and 6. 
Calculations. Spectral data are collected at wave 
lengths N(m)=(l,2, . . . , w} on each sample bag. Treat 
ment of collected spectral data I begins with a smooth 
ing process designed to reduce spectral noise: 
1(1)= W(W(1)) eq 1 
where W represents a linear smoothing operation in 
which 
Calculation of the ?rst derivative of the smoothed spec 
tra removes baseline variations from the spectra of the 
bag: 
. eq 2 
dNUn) I 
A region of interest (i.e., a wavelength region where 
scattering is expected to be observed from cells) is then 
selected in the spectra of each bag. The region in this 
work encompasses one-third of the recorded wave 
length spectrum, leading to s(,)=[w/3]. A separate set 
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of derivative spectra is then calculated for the region of 
interest: 
The two spectra from each bag that show the most 
distinguishing spectral features are selected by: 
The distinctive spectra, HQ) and Hg), are combined by: 
to form an augmented spectral matrix that is useful in 
quantitative and qualitative analysis. The augmented 
space T thus has d=2u dimensions (columns) with one 
row for each sample bag. 
Generally, another m-by-d matrix v, containing vali 
dation samples, is also assembled from the same source 
as the training set is likewise treated in accordance to 
equations l-15. The sample set V serves as an indicator 
of how well the training set describes its overall popula 
tion variation. New spectra of sample bags under test 
are denoted X and are also treated in accordance to 
equations 1-15 before quantitative or qualitative analy 
SIS. 
Bootstrap distributions are calculated by an operation 
K; and K(T), K(X), and |<(V) are each calculated in this 
manner. The results are the m-by-d arrays B, B0,), and 
B(;/). The operation K(T), for example, begins by ?lling 
a matrix P with sample numbers to be used in bootstrap 
sample sets B6). 
The values in P are scaled to the training-set size by: 
P=[(n- l)P+ 1] cq 17 
A bootstrap sample B“) is then created for each row i of 
the m-by-d bootstrap distribution B by: 
B(;)=IKJ' eq 18 
where K are the elements of the i-th rows of P. The q-th 
row of B is ?lled by the center of the q-th bootstrap 
sample, 
5,187,368 
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n eq 19 
17,1]: _: bum/n 1:1 
and the center of the bootstrap distribution is: 
m eq 20 
q = ‘21 bij/m 
The operation K is then repeated using X and V. 
The multivariate data in the bootstrap distributions 
are then reduced to a univariate form: 
d ‘ 2 
‘mi = .510‘; - 9') 
d 2 
I001~ = 5100011 - q) 
and these distances are ordered and trimmed according 
to a trimming-index set: 
l eq 21 
P(])={mp+l, mp+2, mp+3. . . . , m-mp} eq 24 
to reduce the leverage effects of isolated selections at 
the extremes of the bootstrap distributions. 
Cumulative Distribution Functions (CDFs) for QQ 
plotting are formed by: 
Graphing either Cu») or cm on the ordinate versus 
C(,) on the abscissa produces a standard QQ plot. Pat 
terns in the QQ plot can be used to analyze structure in 
the spectral data, and the signi?cance of the correlation 
between Cm and Cm can be used as and indication of 
the existence of subclusters in the spectral data. In the 
plot, a straight line with unit slope and an intercept of 0 
indicates that the two CDFs are essentially identical 
(this line should be observed when CM is on the ordi 
nate and C(,) is on the abscissa). The presence of breaks 
in the line indicates that the CDF on the ordinate is 
multimodal (i.e., that the test set and training set of 
samples are not the same). Sharp bends in the QQ line 
also indicate the presence of more than one distribution 
in the CDF on the ordinate. 
The Pearson Product Moment Correlation Coeffici 
ent between the two integrals or CDFs is used as a 
means of quantifying the differences between the test 
set and training set. The correlation between the two 
integrals decreases steadily with time when an Iv bag is 
contaminated. The correlation coef?cient can be used 
to provide both an indication of the number of microor 
ganisms present in a sealed container as well as how 
long the microorganisms have been present in the con 
tainer and what kind of microorganisms are present in 
the container. The identi?cation of microorganisms is 
accomplished by preparing training sets of each type of 
microorganism expected in the bag and projecting test 
spectra into a training set space or library. Overlap 
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should occur between the test group and one of the 
groups in the training set library if the test bags are 
contaminated with one of the microorganisms used to 
develop the training set library. 
Microorganism Growth. Each bag contained approx 
imately 0.1 mg/mL phenol because this preservative is 
present in the drug formulation of Zantac ® Injection. 
Although this phenol level is insufficient to preserve the 
bags, it is high enough to decrease organism growth 
rates. The slightly elevated ambient temperature of the 
laboratory (30°-35° C.) needed to facilitate operation of 
the near-IR spectrometer also had an effect on microor 
ganism growth. The high ambient temperature in 
creased the growth rate of Pseudomonas aeruginosa but 
decreased the growth rates of Aspergillus niger and Can 
dida albicans. These results were determined by storing 
two duplicate bags for each microorganism at 20°-25° 
C. and determining their growth-rate pro?le over 48 hrs 
in a similar manner. In all cases, solutions remained 
clear throughout the course of the experiment with no 
visible signs of product contamination. 
Near-IR ResultsQThe baselines and peak heights of 
repetitive scans differ somewhat because each spectrum 
was taken at a different location on the Via?ex bag. 
Accordingly, the thickness of the plastic and aqueous 
sample sampled can vary somewhat with each scan. 
Moreover, it is apparent from looking at the near-IR 
spectra of water and the PVC plastic from the bag that 
there are only a few relatively narrow spectral regions 
that may have high sensitivity for looking at back 
reflected or scattered light from cells inside vials or 
bags. The regions around 1450 nm, 1940 nm, and 2500 
nm are effectively obscured by intense water absorp 
tion. The PVC plastic strongly absorbs around 1720 nm. 
Therefore, measurements of Near-IR light returning 
through the water and the bag into the detector in the 
?ber optic probe should be best in the 1100-1360 nm 
region, in a small region around 1600 nm, and in the 
2000-2400 rim region. Unfortunately, the background 
absorption in the 2000-2400 nm region from water is 
still quite high, so this region is virtually useless unless 
all of the material one wishes to examine is adhered to 
the bag wall, which minimizes the amount of water that 
the signal must pass through. The fact that water ab 
sorbs more strongly in the “windows” around 1600 nm 
and 2200 nm than in the window from 1100-1360 rim 
means that one should be able to determine the location 
of microorganisms (a type of depth pro?ling) by look 
ing at spectral absorbances at 1100, 1600, and 2200 nm. 
For example, light scattering from free-?oating micro 
organisms should appear mainly at the 1100-1360 nm 
region. However, microorganisms adhering to the walls 
of the container should appear at the 1600 and 2200 nm 
regions as well as in the 1100-1360 nm region. In fact, 
one might expect them to appear more strongly in the 
1600 and 2200 nm regions than the 1100-1360 nm region 
because their absorption coefficients should be higher at 
the higher near-IR wavel®ngths than at the lower 
near-IR wavelengths. Therefore, because the path 
length for material adhered to the wall would be very 
limited, signals for microorganisms adhering to the 
walls would be expected to be more intense in the 1600 
and 2200 nm wavelength regions. Spatial pro?ling can 
also be accomplished with the near-IR method. A three 
dimensional picture of the contents of the bag can be 
roughly obtained if the bag is held motionless and multi 
ple scans are obtained by moving the ?ber-optic probe. 
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In a preliminary study, full spectral scans from 
1100-2200 nm were obtained for two inoculated bags. 
No signi?cant absorbances were observed in the 1600 
and 2200 nm regions, and it was believed that microor 
ganisms injected into the bags were ?oating freely in 
solution. This study was therefore con?ned to the 
1100-1360 nm region. FIG. 7 shows 12 spectra taken 
from a single bag. These spectra are raw spectra and are 
not processed by any ?ltering methods. They cover the 
entire spectral range from 1100-1360 nm. The spectra 
appear to be relatively noisy because very little light is 
actually re?ected back into the probe from the sample. 
During the ?rst few hrs of cell incubation, few cells are 
in the solution and very little contamination exists. 
Spectra are ?ltered digitally and the 12 spectra taken 
from a single bag are processed to combine them into a 
single spectrum. The process of digitally ?ltering the 
spectra produces smooth and relatively noise-free 
curves such as those shown in FIG. 8. The data in FIG. 
8 come from 30 clean (i.e., uncontaminated), 150 mL, 
5% dextrose bags containing drug. At the early stages 
of contamination, it is important to move the probe 
around the bag because light will be scattered and re 
?ected back to the probe only in a few locations where 
cells are present. The observation of scattering during 
the ?rst few hrs of incubation appears to be somewhat 
of a statistical phenomenon. 
The mathematical problem is ?rst one of identifying 
which of the 12 spectral scans from a bag actually show 
back-scattered light. Identifying and quantifying the 
cells is then accomplished using these particular scans. 
The ?rst derivative is calculated for each of the 12 
spectra and the absolute value of the ?rst derivative in 
the regions near 1100 nm and 1260 nm were examined 
more closely. The sum of the absolute values of the ?rst 
derivatives in these two regions was calculated for each 
ofthe l2 spectra, and the spectra showing the maximum 
sum were used to create a new spectrum. If the same 
spectrum has the maximum absolute value of the ?rst 
derivative at both wavelengths, then it is the only spec 
trum selected, and the resulting, normalized curve is 
symmetrical around the zero wavelength displacement 
point. 
FIGS. 1 and 2 demonstrate why this spectra prepro 
cessing was necessary. FIG. 1 shows 12 scans taken 
from an uncontaminated bag. The solid line shows the 
curve with the maximum absolute value of the ?rst 
derivative. FIG. 2 shows 12 scans taken from a contami 
nated bag containing bacteria. The solid line again 
shows the spectrum with the maximum absolute value 
of the ?rst derivative. It is evident that in clean bags, the 
major source of spectral variation is a baseline variation 
that is predominantly pathlength-dependent. In contam 
inated bags, however, certain spectra will show large 
back scattering peaks that appear as dips in the spectra 
near 1100 nm and 1260 nm. Other scans on the contami 
nated bag will show no back scattering at all. The value 
of the preprocessing technique for IV-bag spectra be 
comes apparent when one examines FIG. 9, which 
shows scans for both uncontaminated and contaminated 
IV bags. In FIG. 9, the displacement value of zero 
represents the back scattering observed at 1100 nm. The 
displacements that appear at 160 nm (both positive and 
negative) represent scattered light observed at 1260 nm 
in the original spectra. In FIG. 9, the lower curve is 
obtained from a contaminated bag while the upper 
curve is obtained from a clean uncontaminated bag. The 
preprocessing and ?ltering procedure is used to select 
12 
the spectra that show the most back scattering of light, 
and these spectra are transformed to principal axes and 
used in the hyperspace integration method. Integration 
of spectral clusters in hyperspace begins with forming 
an estimate of the population distribution in hyperspace 
from the existing training and test sets. This estimate is 
formed by a bootstrap process. 
The training set, test set, and validation set each have 
a CDF. The CDFs for the training set, test set, and 
validation set are given by Equations 10, 11, and 12, 
respectively. Plotting the elements of the vector for the 
' training set on the abscissa versus the elements either of 
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the test set or of the validation set on the ordinate pro 
duces a standard QQ plot. When two CDFs match, the 
result of the QQ plot is a straight line with a slope of l 
and an intercept of 0. However, if the two CDFs are 
different, bends or breaks app *ar in the line of the QQ 
plot. The presence of bends’(where two lines appear in 
the QQ plot with different slopes) indicates the presence 
of two groups in hyperspace with different sizes. The 
presence of a break in the QQ plot line indicates two 
groups in space centered at different locations. The 
presence of both a bend and a break indicates that two 
groups have different sizes and locations in multidimen 
sional hyperspace. Applying linear regression to the 
points on the QQ plot produces an equation whose 
linear coef?cients have particular signi?cance. When 
the spatial volume of the test set is smaller than that of 
the training set, the slope and intercept of the linear 
equation, determined by regression, have values be 
tween 0 and 1. However, when the volume of the test 
set is larger than that of the training set, the coefficients 
of the straight line through the QQ plot tend to have a 
large positive slope and a large negative intercept. Con 
?dence limits are set on the correlation between the two 
CDFs in the QQ plot. The con?dence limits are set 
through a bootstrap process'similar to that used in equa 
tions 1-5. 
FIG. 10 depicts the projection of spectra of a clean 
bag (given by points) and a contaminated bag (given by 
pluses) on a plane in multidimensional hyperspace. The 
plane corresponds to that de?ned by the ?rst and sec 
ond principal axes. FIG. 10 demonstrates that contami 
nated bags produce spectral points in hyperspace that 
are more widely scattered than clean bags. The larger 
spectral cluster of the contaminated bag occurs presum 
ably because its spectra are more variable. The spectra 
in FIG. 10 represent 12 scans taken at various locations 
on each of the two bags (one clean bag spectrum with 
an A/D spike was eliminated). The fact that the pulses 
from the contaminated bag do not overlap the cluster 
formed by the points from the clean bag indicates that a 
spectral difference exists between the clean bag and the 
dirty bag. The distance between the cluster of points 
formed from spectra of the clean bag and the cluster 
formed from the contaminated bag provides an indica 
tion of the amount of material that is responsible for the 
contamination of the dirty bag. The direction of the 
displacement from the center of the clean bag provides 
an identifying spectrum of the material responsible for 
the contamination. Thus, distance gives an indication of 
the number of microorganisms that are present in the 
bag, while direction identi?es the microorganisms pres 
ent in the bag that are responsible for the contamination. 
FIG. 5 gives the growth curve for the yeast, Candida 
albicans. The assay for Candida albicans was obtained 
through standard microbiological assay. The same tech 
nique was employed to determine the concentrations of 
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the bacteria, Pseudomonas aeruginosa, and the mold, 
Aspergillus niger, that appear in FIGS. 4 and 6, respec 
tively. FIG. 11 is calculated from scans that have been 
averaged for each of the 10 bags having the concentra 
tions shown in FIGS. 4, 5, and 6. FIG. 11 is, in effect, a 
“growth curve” of sorts measured by back scattering of 
near-IR light from the bags and/or retrore?ector. The 
98% con?dence limit on back scattering from clean 
training set is given as the horizontal short-dashed line 
in FIG. 11 (the level slightly above 0.93). The solid line 
represents the bacteria, the dotted line represents the 
yeast, and the dashed-dotted represents the mold. After 
inoculation with 165 cfu per IV bag, the bacteria (Pseu 
domanas aeruginosa) were observed at about six hrs at 
an average concentration of 57:4 cfu/mL per bag. 
After injection of 10 cfu yeast (Candida albicans) per 
bag, growth was detected at about four hrs with less 
than an average concentration of 3:1 cfu/mL per bag. 
Injection of the mold (Aspergillus niger) at a level of 12 
cfu per bag allowed detection of growth by near-IR 
spectrometry at about 24 hrs at an average concentra 
tion of 145:20 cfu/mL per bag. 
In FIG. 11, it appears that the yeast is the fastest 
growing species in the bags. However, yeast cells range 
in size from 3-14 pm and are larger than bacterial cells 
(about 0.5-2 pm). At least initially, this size advantage 
might make yeast a better source of light-scattering 
material than the bacteria, which actually grows faster. 
Eventually the bacterial growth appears to overtake the 
size advantage of yeast, and the bacteria then give the 
strongest back-scattering signal. Mold is intermediate in 
size (approximately 3-8 pm) and the slowest growing 
species as indicated by its continued correlation change 
up to nearly 50 hrs, while the correlation of the yeast 
and bacteria seem to have begun to level off, presum 
ably because of the preservative (phenol) also present in 
the drug. What is most noticeable in FIG. 11, however, 
is that even at six hrs and below, the near-1R method is 
able to detect contamination at a 98% con?dence limit 
for yeast and bacteria. FIGS. 4 and 5 indicate that nei 
ther the yeast nor the bacteria have grown signi?cantly 
after this short period of time. Nevertheless, the near-IR 
method is still able to detect this contamination. The 
correlation between spectral clusters at six hrs is poor 
for Candida albicans, Pseudomonas aeruginosa, and As 
pergillus niger. The poor correlation between the spec 
tral clusters at all times (at six hrs and beyond) suggests 
that the near-IR method is able to differentiate between 
these cell types as well as possibly to provide an indica 
tion of the extent of their growth. 
Summary of Results. These data suggest that changes 
in near-IR spectra, taken through the IV bags with a 
?ber optic probe and without product tampering, corre 
late to organism growth. Moreover, spectra also distin 
guish between bags contaminated with different classes 
of microorganisms. Integration of the method of the 
invention with mechanical techniques in product pro 
cessing will allow an on-line sterility assurance method 
in parenteral-production facilities, particularly for fill 
ing processes e.g., aseptic-?ll that require very careful 
control and monitoring because of less than desirable 
assurance levels. The inability in the prior art to test all 
parenteral units in an automated fashion is a serious 
limitation to conventional microbiologic testing, partic 
ularly in cases where microbial contamination is not 
distributed uniformly throughout a batch (Henry L. 
Avallone, J. Parenter. Sci. Technol. 1985, 39(2), 75-79 
and Henry I... Avallone, J. Parenter. Sci. T echnol. 1986, 
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40(2), 56-57). It is very difficult, if not impossible, to 
detect a small percentage of contaminated units within 
a large batch. Near-IR spectrometry with a ?ber-optic 
probe according to the present invention can be used as 
an alternative or adjunct method to conventional mi 
crobiologic testing in quality assurance and other appli 
cations where large quantities of cells must be identi?ed 
and quanti?ed in a relatively short period of time. 
The variation in replicate spectra taken from the same 
IV bag is larger than that observed with other contain 
ers because of the ?exibility of the PVC plastic and 
poor near-IR transparency. To reduce the number of 
replicate scans needed and to improve con?dence statis 
tics, further optimization and improvements can be 
carried out in the sampling procedure, e.g., configura 
tion of the optical probe, sample container and wave 
length range scanned. Glass containers positioned di 
rectly in contact with the optical probe should provide 
even better results because glass is more rigid and offers 
greater transparency in the near-IR spectral region. 
EXAMPLE 2 
The procedure of Example 1 is repeated using glass 
vials in the place of PVC IV bags with, however the 
following changes. 
Sterile and unsterile clear glass vials (10 cc, Type I 
borosilicate) containing a nutrient medium (T rypticase 
Soy Broth) were scanned for 1100-1360 nm using the 
identical spectrophotometer and data collection system 
to that described in Example 1. However, in this exam 
ple, the bottom of the vials were placed directly on top 
the sample window of the ?ber-optic diffuse-re?ectance 
probe. Unsterile vials had been injected with one of 
several species of bacteria, which were allowed to grow 
to produce desired levels of contamination. 
Ten repetitive scans of each vial were taken at 
slightly different positions on the bottom of the vial at 0, 
6, 12, 18, 24, and 48 hrs after injection of bacteria. The 
spectra were ?ltered by a smoothing routine, and the 
rest of the analysis was performed as in Example 1. Test 
spectra recorded at these later time intervals were then 
compared to the “standard" spectra obtained a time 
zero. Such analysis allows vials that are contaminated 
with bacteria or other microorganisms to be distin 
guished from uncontaminated units. 
Abbreviations: 
1V intravenous 
PVC polyvinyl chloride 
mL milliliters 
nm nanometers 
QQ quantile-quantile 
CDF Cumulative Distribution Functions 
near-IR near infrared radiation 
cfu colony forming units 
mg milligrams 
FDA US. Food and Drug Administration 
USP United States Pharmacopeia 
ATCC American Type Culture Collection 
hrs hours 
eq equation 
Special de?ned operations: 
LIST OF SYMBOLS 
W linear ("moving average") smoothing 
d(f(x))/dx derivative of f(x) 
r random number on 0 < x < 1; Monte Carlo 
15 
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5,187,368 
16 
-continued 
LIST OF SYMBOLS 
integration of continuous uniform 
distribution 
K(Z) creates a bootstrap distribution 5 
containing in elements for a set of real 
samples, and ?nds the center of this 
bootstrap distribution 
[x] the greatest‘integer function of a 
scalar, matrix, or array 
a(x) ordered elements of x (x is a matrix or 10 
array) 
= equals, or "is replaced by" when the 
same variable appears on both sides of = 
Scalars: 15 
n the training-set. test-set, and 
validation-set size, i.e., the number of 
samples that the set contains 
d the number of wavelengths and the 20 
dimensionality of the analytical space 
in the number of sample-set replications 
forming a bootstrap distribution (user 
determined) 
i an index for counting rows in a matrix or 
array 25 
j an index for counting columns in a 
matrix or array 
n], the number of replicate spectral points 
falling inside a hypercylinder 
p proportion of a distance distribution to 
trim from each end of the distribution 30 
u the number of spectra collected from a 
single simple bag 
w the number of wavelengths collected from 
a single sample bag 
s, an index marker for a wavelength region 
of interest 35 
p1 the index number of a spectrum showing 
the greatest overall signal in a set of u 
spectra 
p; the index number of a spectrum showing 
the greatest analytical signal over a 
wavelength region of interest in a set of 40 
u spectra 
‘9 the difference between the absorbances 
of two spectra from a single bag at the 
lowest wavelength 
Matrices, vectors, and arrays: 45 
NW) = (nwlpw wavelength vector recorded by 
spectrometer 
hd!) = (l(d!)1j)u.w ?rst derivatives of all 50 
spectra collected from a 
single bag 
1(1) = (l(])|j)u_w smoothed set of u spectra 
collected from a single bag 
1 = (i(,j)u_w set of u spectra as collected 
from a single bag 
1(a) = (l(d2)|j)u,w.” ?rst derivative of region 55 
of interest 
IQ!) = Gum)” sum of absolute value of ?rst 
derivative of full spectra 
1(3) = (i(;2),‘)u sum of absolute value of ?rst 
derivative of wavelength region 
of spectralinterest 60 
HQ) = (hj)w spectrum selected by the index 
Pl 
Hm = (hj) spectrum selected by the index 
P2 
B = ®,j)m_d m-by-d bootstrap distribution 
of training-set sample spectra 65 
B“) = (bij)m_d bootstrap distribution of 
test-setsample spectra 
BU») = (bl?mj bootstrap distribution of 
validation~set sample spectra 
5(1) = (smrlm 
500 = ($000," 
center of the bootstrap 
distribution B 
training-set sample numbers 
selected for the bootstrap 
sarnple sets used to calculate 
bootstrap distribution 
training-set sample spectra 
test-set sample spectra 
validation'set sample spectra 
training-set sample numbers 
selected for a particular 
bootstrap sample 
bootstrap sample set used to 
calculate single rows of a 
bootstrap distribution 
Euclidean distances of 
training-set replicates from 
C, the center of the bootstrap 
distribution of the training 
set 
Euclidean distances of test 
set replicates from C 
Euclidean distances of 
validation-set replicates from 
C 
set of (tn-2pm) indices used 
for trimming distance 
distributions 
cumulative distribution 
function (CDF) formed by the 
trimmed and ordered elements of 
the training-set bootstrap 
distribution; CDF has (2m-4pm) 
elements 
CDF formed by the trimmed and 
ordered elements of the test 
set and training-set bootstrap 
distributions 
CDF formed by the trimmed and 
ordered elements of the 
validation~set and training-set 
bootstrap distributions 
What is claimed is: 
1. A method of detection of microorganisms in a 
liquid sample to be tested, which comprises i) obtaining 
near infrared spectra in the range of about 1100 to 1360 
nanometers of said liquid sample at a plurality of loca 
tions within said liquid sample, ii) obtaining a near infra 
red spectrum in the range of about 1100 to 1360 nano 
meters of a standard sample and iii) comparing said 
liquid sample spectra to said standard sample spectrum 
with computer assistance. 
2. The method of claim 1, wherein said liquid sample 
is an aqueous liquid sample. 
3. The method of claim 1, wherein said microorgan 
isms are yeast bacteria or mold. 
4. The method of claim 1, wherein said liquid sample 
is held in a container, which is at least partially transpar 
ent to at least one wavelength of near-infrared light. 
5. The method of claim 4, wherein said container is a 
container of glass or a polymer. 
6. The method of claim 5, wherein said polymer is 
polyvinyl chloride. 
7. The method of claim 1, wherein said liquid sample 
comprises water and dextrose or sodium chloride. 
8. The method of claim 1, wherein said liquid sample 
comprises a 5% (w/v) aqueous dextrose solution or a 
0.9% (w/v) aqueous sodium chloride solution. 
9. The method of claim 1, wherein said comparison of 
the near-infrared spectrum of said liquid sample to that 
of the standard sample is a comparison of the near-infra 

